The first two patients have been registered to the IMAGO study (Chief Investigator: Dr Simon Lord), a single arm exploratory study examining the feasibility of imaging glioblastoma pH using CEST-MRI. The study is managed by OCTO (Oncology Clinical Trials Office) and sponsored by the University of Oxford.